Laddar...
Monitoring therapeutic monoclonal antibodies in brain tumor
Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...
Sparad:
| I publikationen: | MAbs |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/ https://ncbi.nlm.nih.gov/pubmed/25484065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|